Silymarin Administration Attenuates Cirrhotic-induced Cardiac Abnormality in the Rats: A Possible Role of β(1)-adrenergic Receptors and L-type Voltage-Dependent Calcium Channels

BACKGROUND: Cirrhotic cardiomyopathy is a well-recognized cardiac dysfunction in cirrhotic patients. Studies have confirmed the protective effects of silymarin in different types of cardiac injury. This study aimed to examine the effectiveness and molecular mechanism of silymarin against myocardial...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayat, Gholamreza, Mazloom, Roham, Hashemi, Seyed Ali, Pourkhalili, Khalil, Fallah, Parviz, Shams, Alireza, Esmaeili, Parvaneh, Khalili, Azadeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339107/
https://www.ncbi.nlm.nih.gov/pubmed/35919076
http://dx.doi.org/10.30476/IJMS.2021.90750.2172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339107/
https://www.ncbi.nlm.nih.gov/pubmed/35919076
http://dx.doi.org/10.30476/IJMS.2021.90750.2172

Ejemplares similares